These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
45. Detection of interleukin and interleukin-receptor mRNA in human heart by polymerase chain reaction. Han RO; Ray PE; Baughman KL; Feldman AM Biochem Biophys Res Commun; 1991 Dec; 181(2):520-3. PubMed ID: 1836725 [TBL] [Abstract][Full Text] [Related]
46. Polymerase chain reaction-based mRNA quantification using an internal standard: analysis of oncogene expression. Scheuermann RH; Bauer SR Methods Enzymol; 1993; 218():446-73. PubMed ID: 7685470 [No Abstract] [Full Text] [Related]
47. Rejection--more than the eye can see. Strom TB N Engl J Med; 2005 Dec; 353(22):2394-6. PubMed ID: 16319390 [No Abstract] [Full Text] [Related]
49. PCR amplification of mRNA directly from a crude cell lysate prepared by thermophilic protease digestion. Fung MC; Fung KY Nucleic Acids Res; 1991 Aug; 19(15):4300. PubMed ID: 1870987 [No Abstract] [Full Text] [Related]
50. A simple and rapid method to analyze specific mRNAs from few cells in a semi-quantitative way using the polymerase chain reaction. Golay J; Passerini F; Introna M PCR Methods Appl; 1991 Nov; 1(2):144-5. PubMed ID: 1842933 [No Abstract] [Full Text] [Related]
51. mRNA differential display: application in the discovery of novel pharmacological targets. Wang X; Ruffolo RR; Feuerstein GZ Trends Pharmacol Sci; 1996 Aug; 17(8):276-9. PubMed ID: 8810872 [No Abstract] [Full Text] [Related]
52. An RNA-competitive polymerase chain reaction method for human matrix gamma-carboxyglutamic acid protein mRNA measurement. Zhao J; Nishimoto SK Anal Biochem; 1995 Jun; 228(1):162-4. PubMed ID: 8572273 [No Abstract] [Full Text] [Related]
53. Outfoxing Rejection: Urinary FOXP3 mRNA, TCMR, and the Fate of Allografts. Tedla FM; Sanchez Russo L; Menon MC Transplantation; 2021 Aug; 105(8):1662-1663. PubMed ID: 33031219 [No Abstract] [Full Text] [Related]
54. Screening for bioactive compounds targeting the cellular signal transduction pathway using an RT-PCR-based bioassay system. Hakamatsuka T; Tanaka N Biol Pharm Bull; 1997 Apr; 20(4):464-6. PubMed ID: 9145233 [TBL] [Abstract][Full Text] [Related]
55. Gene therapy with AdV-IL2 (TG 1021) in unresectable digestive adenocarcinoma. Phase I-II study, first inclusions. Gilly FN; Sayag-Beaujard AC; Bienvenu J; Aymard M; Touraine-Moulin F; Favrot M; Trillet-Lenoir V; Pavirani A; Courtney M; François Y; Pellet O; Gaillard C; Glehen O; Banssillon V; Vignal J; Ross M Adv Exp Med Biol; 1998; 451():527-30. PubMed ID: 10026922 [No Abstract] [Full Text] [Related]
56. Oligo(dT)-immobilized pipette tip: efficient new methodology for mRNA preparation and direct gene amplification. Eguchi K; Hamaguchi Y; Aso Y; Shioiri T; Ogura M; Mitsuhashi M Clin Chem; 1998 Oct; 44(10):2208-10. PubMed ID: 9761262 [No Abstract] [Full Text] [Related]